What are the evidence based public health interventions for prevention and control of NCDs in relation to India

Indian Journal of Community Medicine

Volumn 36, Issue SUPPL., 2011, Pages

  Singh, Kavita ^a   Reddy, K Srinath ^b   Prabhakaran, Dorairaj ^c  

^a Centre for Chronic Disease Control (CCDC)   (India)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c CARRS COE   (India)

Author keywords

Evidence base; India; NCD; public health interventions

Indexed keywords

EID: 84859797983     PISSN: 09700218     EISSN: 19983581     Source Type: Journal    
DOI: 10.4103/0970-0218.94705     Document Type: Review

References (64)

1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601. (Pubitemid 28090690)
2. Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, et al. Chronic diseases and injuries in India. Lancet 2011;377:413-28.
3. Leader SR, Greenberg H, Liu H, Esson K. A race against time. The challenge of cardiovascular disease in developing economies. New York: Columbia University; 2004.
4. Ebrahim S, Smith GD. Systematic review of randomized controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997;314:1666-74. (Pubitemid 27232040)
5. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-57. (Pubitemid 29219203)
6. Rose G. Sick individuals and sick populations. 1985. Bull World Health Organ 2001;79:990-6.
7. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32-8. (Pubitemid 15109489)
8. Jha P, Chaloupka FJ. Curbing the epidemic: Governments and the economics of tobacco control. Washington DC, World Bank; 1999.
9. Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 2004;328:977-80. (Pubitemid 38530365)
10. PellJR Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008;359:482-91.
11. WHO report on the global TOBA CCO epidemic, Warning about the dangers of tobacco - mpower. 2011.
12. WHO Global report: Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005.
13. Hawks D SK, McBride N, Jones R Stockwell T. Prevention of psychoactive substance use: A selected review of what works in the area of prevention. Geneva: World Health Organization; 2002.
14. Grant BF, Stinson FS, Harford TC. Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up. J Subst Abuse 2001;13:493-504. (Pubitemid 38198158)
15. Mahal A. What works in alcohol policy? Evidence from rural India. Mumbai: Economic and Political weekly; 2000. p. 3959-68.
16. Sinha DN, Gupta PC, Pednekar MS. Prevalence of smoking and drinking among students in north-eastern India. Natl Med J India 2003;16:49-50. (Pubitemid 36503242)
17. National Drug Research Institute Reports, Australia: 1999. Available from: http://ndri.curtin.edu.au/research/naip.cfm.
18. Abraham J, Chandrasekaran R, Chitralekha V. A prospective study of treatment outcome in alcohol dependence from a deaddiction centre in India. Indian J Psychiatry 1997;39:18-23. (Pubitemid 33246225)
19. Prasad S, Murthy P, Subbakrishna DK, Gopinath PS. Treatment setting and follow-up in alcohol dependence. Indian J Psychiatry 2000;42:387-92. (Pubitemid 33215720)
20. Benegal V MP, Shantala A, Janakiramaiah N. Alcohol related problems. A manual for medical officers. Bengaluru, India: NIMHANS pub no 41, ISBN 81-900-992-4-8; 2001.
21. Murthy P BV, Sankaran L. The Workplace Alcohol Prevention and Activity: the KSRTC audit. Project Report. 2004.
22. Roman PM, Blum TC. The Workplace and Alcohol Prevention. Alcohol Res Health 2002;26:49-57.
23. Pidd K BJ, Harrison JE, Roche AM, Driscoll TR, Newson RS. Alcohol and work: Patterns of use, workplace culture and safety. 2006. Available from: http://www.nisu.flinders.edu.au/pubs/reports/2006/injcat82.pdf.
24. Altman DG. A framework for evaluating community-based heart disease prevention programs. Soc Sci Med 1986;22:479-87. (Pubitemid 16125476)
25. Zatonski WA, Willett W Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ 2005;331:187-8. (Pubitemid 41039798)
26. Costing a one-year delay to the introduction of mandatory nutrition labelling. Australia New Zealand: Canberra, Food Standards; 2002. Available from: http://www.foodstandards.gov.au/-srcfiles/costing-a-one-year-delay.pdf.
27. Global Strategy on Diet, Physical Activity and Health. Geneva: World Health Organization; 2004.
28. Food Standards Agency health campaign to reduce salt levels and save lives. London: UK, Food Standards Agency; 2004.
29. Matsudo SM, Matsudo VR, Araujo TL, Andrade DR, Andrade EL, de Oliveira LC, et al. Physical activity promotion: experiences and evaluation of the Agita Sao Paolo Program using the ecological mobile model. J Phys Act Health 2004;1:81-97.
30. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-28.
31. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-24.
32. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10. (Pubitemid 32064838)
33. Katan MB, Zock PL, Mensink RP. Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 1995;61(6 Suppl):1368S-73S.
34. Kris-Etherton PM. Monosaturated fatty acids and risk of cardiovascular disease. Circulation 1999;100:1253-8.
35. Srinath Reddy K, Katan MB. Diet, nutrition and the prevention of hypertension and cardiovascular diseases. Public Health Nutr 2004;7:167-86. (Pubitemid 38294516)
36. Perdue WC, Stone LA, Gostin LO. The built environment and its relationship to the public's health: the legal framework. Am J Public Health 2003;93:1390-4. (Pubitemid 38477655)
37. Gay JL, Saunders RP, Dowda M. The Relationship of Physical Activity and the Built Environment within the Context of Self-Determination Theory. Ann Behav Med 2011;42:188-96.
38. Pietinen P, Vartiainen E, Seppanen R, Aro A, Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med 1996;25:243-50. (Pubitemid 26177566)
39. Puska P, Vartiainen E, Tuomilehto J, Salomaa V, Nissinen A. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. Bull World Health Organ 1998;76:419-25. (Pubitemid 28469275)
40. Puska P, Nissinen A, Tuomilehto J, Salonen JT, Koskela K, McAlister A, et al. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health 1985;6:147-93.
41. Dowse GK, Gareeboo H, Alberti KG, Zimmet P, Tuomilehto J, Purran A, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the noncommunicable disease intervention programme in Mauritius. Mauritius Noncommunicable Disease Study Group. BMJ 1995;311:1255-9.
42. Tian HG, Guo ZY, Hu G, Yu SJ, Sun W, Pietinen R et al. Changes in sodium intake and blood pressure in a community-based intervention project in China. J Hum Hypertens 1995;9:959-68. (Pubitemid 26008388)
43. Nissinen A, Berrios X, Puska P. Community-based noncommunicable disease interventions: Lessons from developed countries for developing ones. Bull World Health Organ 2001;79:963-70. (Pubitemid 33027176)
44. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
45. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53. (Pubitemid 30051645)
46. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
47. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
48. Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, et al. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J 2002;23:207-15. (Pubitemid 36358242)
49. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8. (Pubitemid 37093919)
50. Mitra S, Das Gupta A. An estimate of the prevalence of cancer in India. Bull World Health Organ 1960;22:485-92.
51. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middleincome developing countries. Bull World Health Organ 2001;79:954-62. (Pubitemid 33027175)
52. Chen BH, Hong CJ, Pandey MR, Smith KR. Indoor air pollution in developing countries. World Health Stat Q 1990;43:127-38. (Pubitemid 20344073)
53. Smith KR. National burden of disease in India from indoor air pollution. Proc Natl Acad Sci U S A 2000;97:13286-93.
54. Indoor air pollution in developing countries. Lancet 1990;336:1548.
55. Reddy KS, Arora M, Perry CL, Nair B, Kohli A, Lytle LA, et al. Tobacco and alcohol use outcomes of a school based intervention in New Delhi. Am J Health Behav 2002;26:173-81.
56. Perry CL, Stigler MH, Arora M, Reddy KS. Preventing tobacco use among young people in India: Project MYTRI. Am J Public Health 2009;99:899-906.
57. Dell Center for Healthy Living. Project ACTIVITY (Advancing Cessation of Tobacco In Vulnerable Indian Tobacco Consuming Youth). 2010. Available from: http://www.sph.uth.tmc.edu/DellHealthyLiving/default.aspx?id=3995. [Last cited on 2010 June 4].
58. Prabhakaran D, Jeemon P, Goenka S, Lakshmy R, Thankappan KR, Ahmed F, et al. Impact of a worksite intervention program on cardiovascular risk factors: a demonstration project in an Indian industrial population. J Am Coll Cardiol 2009;53:1718-28.
59. Somannavar S, Lanthorn H, Deepa M, Pradeepa R, Rema M, Mohan V Increased awareness about diabetes and its complications in a whole city: effectiveness of the "prevention, awareness, counselling and evaluation" [PACE] Diabetes Project [PACE-6]. J Assoc Physicians India 2008;56:497-502.
60. Prabhakaran D, Jeemon P, Mohanan PP, Govindan U, Geevar Z, Chaturvedi V, et al. Management of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme. Natl Med J India 2008;21:107-11.
61. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P et al. Priority actions for the noncommunicable disease crisis. Lancet 2011;377:1438-47.
62. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln R et al. UN High-Level Meeting on Noncommunicable Diseases: addressing four questions. Lancet 2011;378:449-55.
63. Reddy KS GP, editors. Tobacco control in India. New Delhi: Ministry of Health and Family Welfare, Government of India; 2004.
64. Mohan S, Reddy KS, Prabhakaran D. Chronic Noncommunicable Diseases in India - Reversing the tide. New Delhi, India: Public Health Foundation of India; 2011.